683772-11-4

Basic information

• Product Name: Piperidine, 4-(1-pyrrolidinylmethyl)- (9CI)
• Synonyms: Piperidine, 4-(1-pyrrolidinylmethyl)- (9CI);4-(pyrrolidin-1-ylmethyl)piperidine(SALTDATA: 2HCl)
• CAS NO: 683772-11-4
• Molecular Formula: C10H20N2
• Molecular Weight: 168.2792
• Product Categories: AMINETERTIARY
• Mol File: 683772-11-4.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: Piperidine, 4-(1-pyrrolidinylmethyl)- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Piperidine, 4-(1-pyrrolidinylmethyl)- (9CI)(683772-11-4)
• EPA Substance Registry System: Piperidine, 4-(1-pyrrolidinylmethyl)- (9CI)(683772-11-4)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 683772-11-4(Hazardous Substances Data)

Usage

General Description

Piperidine, 4-(1-pyrrolidinylmethyl)- (9CI) is a chemical compound that is commonly used in the pharmaceutical industry as a building block for the synthesis of various drugs and fine chemicals. It is a heterocyclic amine with a piperidine ring and a pyrrolidinylmethyl substituent. Piperidine, 4-(1-pyrrolidinylmethyl)- (9CI) has been identified as a key intermediate in the production of various pharmaceuticals, including antihistamines, antipsychotic drugs, and anti-anxiety medications. Additionally, it has been found to exhibit potential biological activity and has been the subject of research for its potential therapeutic applications. Overall, this chemical compound plays a significant role in the development of various pharmaceutical products and the advancement of medical research.

Upstream product

• 683772-10-3 4-((pyrrolidin-1-yl)methyl)piperidine-1-carboxylic acid tert-butyl ester 
• 84358-13-4 N-[(tert-butoxy)carbonyl]piperidine-4-carboxylic acid 
• 188979-06-8 tert-butyl 4-(pyrrolidine-1-carbonyl)piperidine-1-carboxylate 
• 35090-95-0 piperidin-4-yl(pyrrolidin-1-yl)methanone 

Relevant articles and documents

Design, synthesis and antitubercular evaluation of benzothiazinones containing a piperidine moiety

We herein report the design and synthesis of benzothiazinones containing a piperidine moiety as new antitubercular agents based on the structure feature of IMB-ZR-1 discovered in our lab. Some of them were found to have good in vitro activity (MIC 1 μg/

Phenylpiperidines and phenylpyrrolidines

Substituted phenylpiperidines and phenylpyrrolidines of formula (I), compositions containing them, and methods of making and using them to treat histamine-mediated conditions.